Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP360832.RAYheW5opUugAD4SZNHKn03svF0mLwitmoZKRauHBCx-E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP360832.RAYheW5opUugAD4SZNHKn03svF0mLwitmoZKRauHBCx-E130_assertion type Assertion NP360832.RAYheW5opUugAD4SZNHKn03svF0mLwitmoZKRauHBCx-E130_head.
- NP360832.RAYheW5opUugAD4SZNHKn03svF0mLwitmoZKRauHBCx-E130_assertion description "[The prevalence of the factor V Leiden mutation (FVL) and the prothrombin G20210A mutation and of homozygosity for the methylenetetrahydrofolate reductase (MTHFR) C677T substitution has been analyzed in a cohort of 175 patients with gastrointestinal adenocarcinoma by the polymerase chain reaction-restriction fragment length polymorphism technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360832.RAYheW5opUugAD4SZNHKn03svF0mLwitmoZKRauHBCx-E130_provenance.
- NP360832.RAYheW5opUugAD4SZNHKn03svF0mLwitmoZKRauHBCx-E130_assertion evidence source_evidence_literature NP360832.RAYheW5opUugAD4SZNHKn03svF0mLwitmoZKRauHBCx-E130_provenance.
- NP360832.RAYheW5opUugAD4SZNHKn03svF0mLwitmoZKRauHBCx-E130_assertion SIO_000772 12115343 NP360832.RAYheW5opUugAD4SZNHKn03svF0mLwitmoZKRauHBCx-E130_provenance.
- NP360832.RAYheW5opUugAD4SZNHKn03svF0mLwitmoZKRauHBCx-E130_assertion wasDerivedFrom befree-2016 NP360832.RAYheW5opUugAD4SZNHKn03svF0mLwitmoZKRauHBCx-E130_provenance.
- NP360832.RAYheW5opUugAD4SZNHKn03svF0mLwitmoZKRauHBCx-E130_assertion wasGeneratedBy ECO_0000203 NP360832.RAYheW5opUugAD4SZNHKn03svF0mLwitmoZKRauHBCx-E130_provenance.